Delivering Medical Innovation in a Value-based World

Delivering Medical Innovation in a Value-based World

Discover the implications for medical innovation as the health care industry transitions to value-based care. Biopharma, medtech, health plans, and provider executives suggest four changes that could encourage innovation as value-based care takes root and evolves. The Deloitte Center for Health Solutions and the Network for Excellence in Health Innovation (NEHI) convened 21 leaders across the health care system including life sciences companies, health plans, providers, academics, non-profits, and patient groups in fall 2015 to discuss how VBC influences innovation, how current VBC models could evolve to encourage innovation, and the strategic considerations for biopharma and medical technology (medtech) companies. Meeting participants pointed out that ongoing cross-stakeholder dialogue is critical to ensure that valuable medical innovations continue to reach patients as VBC models take root and evolve.


Deploy this technology today


Next Article

  • Delivering Medical Innovation in a Value-based World

    Tapping your ERP for healthcare supply chain resiliency

    The healthcare supply chain is under enormous pressure. Ongoing disruptions and workforce challenges have supply chain teams dealing with product shortages and chasing backorders. Add to this …

    Posted Jan 24, 2023

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 7, 2024 at 2:50pm